Literature DB >> 24893146

Regulation of energy metabolism by the skeleton: osteocalcin and beyond.

Mathieu Ferron1, Julie Lacombe2.   

Abstract

The skeleton has recently emerged as an endocrine organ implicated in the regulation of glucose and energy metabolism. This function of bone is mediated, at least in part, by osteocalcin, an osteoblast-derived protein acting as a hormone stimulating insulin sensitivity, insulin secretion and energy expenditure. Osteocalcin secretion and bioactivity is in turn regulated by several hormonal cues including insulin, leptin, the sympathetic nervous system and glucocorticoids. Recent findings support the notion that osteocalcin functions and regulations are conserved between mice and humans. Moreover, studies in mice suggest that osteocalcin could represent a viable therapeutic approach for the treatment of obesity and insulin resistance. In this review, we summarize the current knowledge on osteocalcin functions, its various modes of action and the mechanisms implicated in the control of this hormone.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Energy metabolism; Glucose metabolism; Insulin; Osteoblast; Osteocalcin; Osteoclast

Mesh:

Substances:

Year:  2014        PMID: 24893146     DOI: 10.1016/j.abb.2014.05.022

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  58 in total

Review 1.  Endocrine roles of vitamin K-dependent- osteocalcin in the relation between bone metabolism and metabolic disorders.

Authors:  Ebtesam Abdullah Al-Suhaimi; Meneerah Abdulrahman Al-Jafary
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 2.  Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.

Authors:  Meghan E McGee-Lawrence; Thomas A White; Nathan K LeBrasseur; Jennifer J Westendorf
Journal:  Mol Cell Endocrinol       Date:  2015-02-07       Impact factor: 4.102

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

4.  Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.

Authors:  Meghan E McGee-Lawrence; Jessica L Pierce; Kanglun Yu; Natasha R Culpepper; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Cell Physiol       Date:  2017-09-12       Impact factor: 6.384

Review 5.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

6.  Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Authors:  D Liu; L Chen; S Dong; Z Peng; H Yang; Y Chen; L Li; H Zhou; R Zhou
Journal:  Osteoporos Int       Date:  2019-06-10       Impact factor: 4.507

7.  Measurement of bioactive osteocalcin in humans using a novel immunoassay reveals association with glucose metabolism and β-cell function.

Authors:  Julie Lacombe; Omar Al Rifai; Lorraine Loter; Thomas Moran; Anne-Frédérique Turcotte; Thomas Grenier-Larouche; André Tchernof; Laurent Biertho; André C Carpentier; Denis Prud'homme; Rémi Rabasa-Lhoret; Gerard Karsenty; Claudia Gagnon; Weiping Jiang; Mathieu Ferron
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-01-14       Impact factor: 4.310

Review 8.  The role of leptin in regulating bone metabolism.

Authors:  Jagriti Upadhyay; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

9.  Reducing Undercarboxylated Osteocalcin With Vitamin K Supplementation Does Not Promote Lean Tissue Loss or Fat Gain Over 3 Years in Older Women and Men: A Randomized Controlled Trial.

Authors:  M Kyla Shea; Bess Dawson-Hughes; Caren M Gundberg; Sarah L Booth
Journal:  J Bone Miner Res       Date:  2016-10-31       Impact factor: 6.741

10.  Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots.

Authors:  Keertik Fulzele; Forest Lai; Christopher Dedic; Vaibhav Saini; Yuhei Uda; Chao Shi; Padrig Tuck; Jenna L Aronson; Xiaolong Liu; Jordan M Spatz; Marc N Wein; Paola Divieti Pajevic
Journal:  J Bone Miner Res       Date:  2017-01-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.